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Mycobacteria, the pathogens that cause tuberculosis and leprosy, establish long-term infections 
in host macrophages. Recent studies, including two genetic screens reported in this issue of Cell 
(Kumar et al., 2010; Tobin et al., 2010), reveal that virulent mycobacteria evade the host immune 
system by stimulating production of anti-inflammatory molecules and inhibiting autophagy.Mycobacterium tuberculosis causes ?8.9 million new cases of 
tuberculosis (TB) and 1.7 million deaths each year (Korenromp et 
al., 2009), and M. leprae causes ?250,000 new cases of leprosy 
annually. In contrast, most nontuberculosis mycobacteria are 
accidental pathogens that cause severe disease only in immu-
nodeficient individuals, such as those with AIDS or cystic fibro-
sis. Disseminated infections with nontuberculosis mycobacteria 
or with the TB vaccine, a rare syndrome called Mendelian Sus-
ceptibility to Mycobacterial Diseases, also can appear in other-
wise healthy individuals (Al-Muhsen and Casanova, 2008). 
Virulent M. tuberculosis enters the lungs via the aerosol route 
and is promptly engulfed by resident macrophages and dendritic 
cells, which trigger a full innate and adaptive immune response in 
the host. This ultimately leads to the activation of macrophages, 
which produce bacteriostatic and bactericidal molecules while 
also increasing the maturation of their phagosomes to help kill the 
engulfed bacteria. In most cases this immune response is insuffi-
cient to eliminate the organism, and M. tuberculosis establishes a 
persistent and dormant infection, probably within macrophages, 
that has a 5%–10% risk of progressing to an active disease during 
an individual’s lifetime.
Genetic analysis of individuals who are highly susceptible to 
nontuberculosis mycobacterial infections, together with stud-
ies of human populations in areas endemic for TB, has provided 
valuable information about key resistance pathways required 
to protect the host against disease progression (Fortin et al., 
2007). However, the mechanisms by which M. tuberculosis and 
other pathogenic mycobacteria initially evade the host immune 
response and establish long-term residency in infected tis-
sues remain largely unknown. Now, two studies in this issue of 
Cell (Kumar et al., 2010; Tobin et al., 2010) use complementary 
genetic approaches to uncover critical host factors that control 
the response of macrophages when they come into contact with 
mycobacteria. Specifically, these studies identify a collection of 
macrophage genes that alter the capacity of mycobacteria to 
replicate and survive inside the host during the initial stages of 
infection.
Mycobacteria Inhibit Autophagy
A major difference between virulent and avirulent species of 
mycobacteria is how they modulate cell death and the autophagy 
pathways of host cells (Figure 1). Autophagy is an innate defense mechanism used by macrophages to destroy foreign invaders. 
During autophagy, an infected phagosome is sequestered in a 
double-membraned organelle, called an autophagosome, which 
eventually fuses with lysosomes to degrade the resident patho-
gen (Figure 1). Phagocytosis of nonpathogenic mycobacteria 
results in both autophagy and apoptosis, leading to the success-
ful elimination of the pathogen (Figure 1). In contrast, phagocyto-
sis of pathogenic mycobacteria, such as M. tuberculosis, inhibits 
autophagy, blocks the acidification of phagosomes, and reduces 
fusion of lysosomes (Flanagan et al., 2009). As a result, M. tuber-
culosis survives and replicates inside immature phagosomes 
(Figure 1). Phagocytosis of virulent M. tuberculosis also inhibits 
the early stage of apoptosis but stimulates necrotic cell death, 
which favors bacterial spread to uninfected cells (Figure 1). The 
net result is a reduction in mycobacterial antigen presentation and 
a sustained M. tuberculosis infection (Gan et al., 2008).
Recent cellular and genetic studies have confirmed that the inhi-
bition of autophagy in macrophages is critical for M. tuberculosis 
pathogenesis. Experimental activation of autophagy can restrict 
intracellular replication and survival of M. tuberculosis (Deretic et 
al., 2009; Jagannath et al., 2009). Meanwhile, rapamycin-induced 
autophagy in infected mouse macrophages causes increased 
acidification and maturation of phagosomes and recruitment of 
autophagy effector molecules to the phagosomes that contain 
mycobacteria (Gutierrez et al., 2004). In addition, mice lacking the 
IRGM1 protein, a phagosomal protein essential for autophagy, 
show increased susceptibility to mycobacterial infection (Mac-
Micking et al., 2003). In humans, variants of the IRGM gene are 
associated with protection from TB in West African populations 
(Intemann et al., 2009).
In this issue, Kumar et al. (2010) now provide evidence that 
autophagy modulation in macrophage cells is a general strat-
egy employed by multiple types of M. tuberculosis isolates to 
evade the host immune system. Using a genome-wide siRNA-
mediated silencing screen, the authors uncovered 275 genes in 
a human macrophage-like cell line that modulate M. tubercu-
losis replication 4 days after infection. This gene list was then 
subjected to an elaborate bioinformatics analysis, including the 
identification of functional partners for the silenced genes. This 
network of genes was then integrated with expression profil-
ing data to identify functionally relevant gene clusters whose 
expression is regulated by infection. The authors repeated Cell 140, March 5, 2010 ©2010 Elsevier Inc. 615
these experiments on seven different field isolates of M. tuber-
culosis, which display varying degrees of virulence in the mac-
rophage-like cell line. Although the effect of siRNA-mediated 
silencing of the 275 validated genes revealed remarkable het-
erogeneity across the different isolates, a subset of 74 siRNAs 
were commonly effective at modulating replication of all seven 
varieties of M. tuberculosis. Interestingly, these invariant host 
factors predominantly functioned through autophagy or were 
associated with its regulation, leading the authors to conclude 
that M. tuberculosis infection of human macrophage-like cells 
activates cellular pathways that inhibit autophagy.
Mycobacteria Stimulate Anti-inflammatory Pathways
In addition to blocking autophagy, virulent mycobacteria appear 
to evade the host immune system by upregulating the production 
of the host’s own anti-inflammatory molecules, such as lipoxin. 
Derived enzymatically from arachidonic acid, lipoxins are small 
molecules that regulate the inflammation process (Figure 1). M. 
tuberculosis infection has been shown to induce production of 
lipoxin A4 in vivo, which acts systemically as a negative regulator 
of the early protective response initiated by T helper cells. In con-
trast, knocking out the enzyme that produces lipoxin A4 in mice 
increases the in vivo expression of proinflammatory factors, such 
as IL-12, interferon IFNγ, and inducible nitric oxide synthase (iNOS), 
reducing bacterial replication in host cells (Bafica et al., 2005).
The new study by Tobin et al. (2010) in this issue nicely con-
firms a critical role for lipoxin signaling during the early stages 
of mycobacteria infection both in humans and in the zebrafish 
(Danio rerio). Using a forward genetic 
screen in zebrafish, the authors iden-
tify mutations that affect the replication 
of M. marinum inside fish embryo cells 
4 days after infection. The majority of 
detected mutations increased suscepti-
bility to infection and enhanced bacte-
rial replication within the zebrafish macrophages. The authors 
mapped one of these mutants (fh112) to the lta4h locus, which 
encodes the leukotriene A4 hydrolase enzyme. This hydrolase 
converts leukotriene A4 into the proinflammatory molecule leu-
kotriene B4.
Passive administration of leukotriene B4 did not correct the 
susceptibility phenotype, suggesting that it is not the loss of 
the proinflammatory molecule that enhances bacterial replica-
tion during the initial stages of infection. Instead, the authors 
propose that the deficiency of leukotriene hydrolase activity 
causes increased accumulation of the anti-inflammatory mol-
ecule lipoxin A4 because the substrate of leukotriene hydrolase 
(leukotriene A4) can also be converted to lipoxin A4 by a parallel 
pathway (Figure 1). In support of this hypothesis, continuous 
administration of lipoxin A4 to fish infected with M. marinum 
caused a modest increase in microbial replication 5 days after 
infection. Further, the authors also detected a genetic inter-
action between the lta4h mutant and the TNF-α proinflamma-
tory pathway and observed increased macrophage necrosis in 
granulomas from lta4h mutant fish.
In support of these new findings by Tobin et al. (2010), other 
studies have recently shown lipoxin A4 to be a key mediator of 
mycobacterial-induced necrotic death of macrophages; this 
activity is antagonized by the proinflammatory factor, prosta-
glandin E2. A deficiency in prostaglandin E synthase increases 
replication of mycobacteria in mice and enhances mycobacterial 
infection in cultured macrophage cells (this phenotype can be 
reversed by addition of prostaglandin E2). Finally, studies in cul-
Figure 1. Macrophage Defense against 
Mycobacteria
(Left) When nonpathogenic mycobacteria (orange) 
are phagocytosed by host macrophages, a num-
ber of protective responses are triggered in the 
macrophage. First, the autophagy pathway con-
verts the infected phagosome into an autopha-
gosome, which eventually fuses with lysosomes, 
and the engulfed pathogen is degraded. Second, 
the upregulation of proinflammatory factors, such 
as prostaglandin E2 (PGE2) and TNF-α, combined 
with the downregulation of anti-inflammatory mol-
ecules, such as lipoxin A4 (LXA4), stimulates apop-
tosis and the successful elimination of the invad-
ing mycobacteria. 
(Right) In contrast, phagocytosis of pathogenic 
mycobacteria (red), such as M. tuberculosis, trig-
gers a different response in macrophages. The au-
tophagy pathway is inhibited (Kumar et al., 2010), 
resulting in the production of immature autopha-
gosomes, where M. tuberculosis can persist and 
replicate. The accumulation of anti-inflammatory 
factors, such as LXA4, combined with a decrease 
in proinflammatory factors, such as TNF-α (Tobin 
et al., 2010), suppresses apoptosis and stimulates 
necrosis, which is known to be associated with 
bacterial proliferation and survival.616 Cell 140, March 5, 2010 ©2010 Elsevier Inc.
tured cells in vitro comparing macrophage responses to virulent 
versus avirulent forms of M. tuberculosis show that infection of 
macrophages with avirulent strains is associated with increased 
production of prostaglandin E2, limited bacterial replication, and 
protection against necrotic cell death (Chen et al., 2008).
Recently, Divangahi et al. (2009) further defined the mecha-
nistic basis for the differential effect of lipoxin A4 and prosta-
glandin E2 on M. tuberculosis replication in macrophages and 
susceptibility to TB in vivo. They found that the application of 
exogenous prostaglandin E2 stimulated the repair of mem-
branes damaged by M. tuberculosis infection and prevented 
necrotic cell death. On the other hand, macrophages incapable 
of producing lipoxin A4 showed reduced mycobacterial replica-
tion, increased apoptosis, and reduced necrosis. These in vitro 
results were corroborated by in vivo studies using a mouse 
strain that is incapable of producing lipoxin A4.
The study by Kumar et al. (2010) now provides evidence that 
perturbation of inflammatory signaling during mycobacterial 
infection is likely to involve multiple parallel pathways. Using 
the siRNA-mediated silencing screen, together with bioinfor-
matics analyses and expression profiling data, the authors 
found that M. tuberculosis infection upregulates a large array 
of genes involved in anti-inflammatory and immunosuppressive 
signaling, such as AKT, Toll-like receptor (TLR) 8, and media-
tors of T helper 2 cell responses, such as IL-4 and GATA3. M. 
tuberculosis infection also downregulates a large number of 
genes involved in proinflammatory signaling, including those 
encoding cytokines and chemokines (such as IL-1B, IL-6, IL-7, 
and CCL11), a pattern recognition receptor (NOD2), and cell-
associated signaling molecules involved in the response to 
infection (CXCL5, IRAK2, IRF-4, NOD2, and MYD88).
Thus, it appears that the balance between the prostaglan-
din and lipoxin pathways critically affects the cellular fate of an 
infected macrophage. The production of proinflammatory fac-
tors, such as prostaglandin E2, favors the successful elimination 
of the pathogen, whereas the production of anti-inflammatory 
factors, such as lipoxin A4, favors the establishment of patho-
genesis. Any host factors that alter the balance of these pro- and 
anti-inflammatory components will probably have a significant 
impact on the ultimate outcome of M. tuberculosis infection.
Human Genetics of TB Susceptibility
The remaining question is, then, to what degree is TB susceptibil-
ity in humans modulated by naturally occurring genetic variants 
within genes that are involved in these inflammatory signaling 
pathways. Here, Tobin et al. (2010) found that heterozygosity at 
two intragenic LTA4H single nucleotide polymorphisms (SNPs) 
strongly protected individuals against pulmonary and menin-
geal TB in a case control study of Vietnamese TB patients. Strik-
ingly, the same protective effect of heterozygosity was observed 
for death from meningeal TB. Further, in a sample from Nepal, 
heterozygosity for the identical markers was also associated 
with borderline significant protection against a form of leprosy. 
In support of these new findings, another recent study found 
that polymorphic variants in the 5-lipoxygenase gene, another 
critical component of the lipoxin signaling pathway, are associ-
ated with increased susceptibility to TB in West African cases 
(Herb et al., 2008). Furthermore, a recent genome-wide study found that polymorphic variants in members of the NOD2 sig-
naling pathway, a strong mediator of inflammation in the early 
response to infection, are associated with differential suscepti-
bility to leprosy (Zhang et al., 2009).
These important observations of Tobin and colleagues urgently 
need to be replicated, and this should be readily accomplished in 
follow-up studies. A more difficult problem is the characterization 
of the underlying mechanism for the protective effect of heterozy-
gosity. This issue is complicated further by the fact that all tested 
SNPs within the LTA4H gene, irrespective of their association with 
mycobacterial disease, showed strong deviations from expected 
ratios of homozygotes and heterozygotes (i.e., deviations from 
Hardy Weinberg equilibrium). During evolution, heterozygotes 
may display greater evolutionary fitness than homozygotes at 
either allele, or selective pressure may be variable within the 
same population. This results in balancing selection, which acts 
to maintain allelic variation within a population. Although the con-
cept of balancing selection is well established, there are very few 
examples of a disease-specific advantage to heterozygosity. 
There are a number of possible explanations for the TB-related 
effect. For example, combinations of rare variants may be neces-
sary for disease susceptibility, or heterozygosity may help prop-
erly balance pro- and anti-inflammatory cytokine production dur-
ing a successful immune response. The surprising finding of a 
mycobacterial heterozygous advantage needs to be addressed in 
a systematic manner in carefully designed follow-up studies that 
also include nonmycobacterial inflammatory disorders.
What Have We Learned?
The Kumar et al. (2010) and Tobin et al. (2010) studies both 
focused exclusively on the innate immune response to myco-
bacterial infection but still detected different types of genes 
associated with mycobacterial survival and replication. The 
majority of mutations detected in the zebrafish screen (Tobin 
et al., 2010) interfered with host resistance to infection and 
caused increased replication of M. marinum in vivo (e.g., the 
fh112 class). In contrast, the vast majority of genes (270 out of 
275) identified by Kumar et al. (2010) in their siRNA-mediated 
silencing screen in human macrophage-like cells are genes that 
positively contribute to M. tuberculosis survival in macrophages 
(because silencing reduced mycobacterial replication). In fact, 
only in the case of 5 genes did siRNA silencing cause a signifi-
cant increase in M. tuberculosis counts in infected cells. The 
annotation of these genes does not reveal any obvious link to 
known macrophage defenses against mycobacteria for at least 
4 of these 5 genes (encoding low-density lipoprotein receptor-
related protein 5-like, the glycerol-3-phosphate transporter, 
synaptotagmin-1, and thyroid hormone receptor interactor 11).
One possible reason for the different outcomes in the two stud-
ies is that many mutants of the fh112 phenotype may in fact be in 
the same complementation group, with mutations in lth4a (or its 
associated pathway) being extremely frequent in this group. Such 
potential overrepresentation would alter the balance between 
mutations that promote and those that reduce mycobacterial 
infection. A second possibility is that the two experimental systems 
sample different aspects of the host response to infection: The 
fish screen sampled all aspects of the innate immune response in 
vivo, including cell-to-cell interactions, whereas the siRNA-medi-Cell 140, March 5, 2010 ©2010 Elsevier Inc. 617
ated silencing screen targeted genes that act in isolated cells and 
at a later time in infection. Yet a third possibility is that the mac-
rophage-like cells used in the silencing screen have few natural 
antimycobacterial defenses and are simply extremely permissive 
to M. tuberculosis infection and replication. In this scenario, it may 
be difficult to detect genes whose inhibition causes increased 
replication. A final more speculative interpretation of the results is 
that M. tuberculosis has evolved as an intracellular pathogen so 
that successful residency and replication are dependent on the 
antimicrobial responses of macrophages. Paradoxically, in such a 
situation, replication of M. tuberculosis would be abrogated in the 
absence of a fully developed macrophage response.
Another contrasting aspect of the two studies is the use of 
different mycobacterial species to identify key host pathways. 
Tobin et al. (2010) were able to uncover an infection strategy for 
M. marinum, a fish pathogen, that was already established for 
M. tuberculosis, suggesting that different mycobacterial patho-
gens trigger similar host responses and defense mechanisms. In 
contrast, Kumar et al. (2010) restricted their study to virulent M. 
tuberculosis and observed large variations across different field 
isolates. The degree to which this variability might be attributable 
to genotypic versus phenotypic variations among isolates is dif-
ficult to determine because of the presence of both genetic diver-
sity and varying degrees of drug resistance. Future studies should 
test for lineage-specific effects by comparing fully drug-sensitive 
organisms of differing genotypes or by testing for antibiotic resis-
tance by comparing isolates of the same genotype. Nonetheless, 
an increasing body of literature suggests that genetic variability in 
M. tuberculosis translates into phenotypic variability in man, with 
some reports describing an association between host genetic 
variants and the risk of disease due to specific M. tuberculosis 
strains (Intemann et al., 2009). A key question for future mycobac-
terial-host interaction studies will be to delineate processes that 
are generic to mycobacterial infections, specific to a limited sub-
set of pathogenic mycobacteria, or unique to selected lineages of 
M. tuberculosis.
The two studies in this issue of Cell agree that host responses 
that are critical for the establishment of infection take place 
very soon after an encounter with host macrophages. These 
include early production of proinflammatory or anti-inflamma-
tory lipid mediators, induction of Toll-like receptor/NOD-like 
receptor signaling, and regulation of autophagy and apoptotic 
or necrotic cell death. Because both of these studies focused 
exclusively on the innate immune response during the very 
early stages of mycobacterial infection, the relevance of their 
findings to an established or chronic infection is not known. 
However, recent results from genome-wide association stud-
ies in cohorts of leprosy patients and in individuals suffering 
from chronic inflammatory bowel disorders have detected a 
strong overlapping genetic component to the two conditions 
(including the NOD2 signaling pathway), highlighting the critical 
importance of early pathogen sensing and early proinflamma-
tory events on the subsequent development of chronic states 
of infection and inflammation (Schurr and Gros, 2009).
Such proteins and pathways mediating physiological responses 
of host cells to mycobacterial infection seemingly represent excel-
lent targets for pharmacological intervention. However, the notion 
that promoting early inflammation may be of general benefit in 618 Cell 140, March 5, 2010 ©2010 Elsevier Inc.fighting different infections must be approached with caution. For 
example, studies in mouse models have shown that robust early 
inflammatory and innate immune responses are beneficial in the 
fight against certain intracellular infections, but these responses 
can be detrimental when combating infection with other patho-
gens such as the parasite Plasmodium berghei, which causes 
cerebral malaria in mice. In this case, pathogenesis of P. berghei 
is driven by excessive inflammation of the host microvasculature 
(De Souza et al., 2009). Therefore, modulation of this delicate 
balance, not only by host factors but also by microbial virulence 
determinants, will have a major impact on the outcome of human 
encounters with many types of undesirable intracellular visitors, 
including mycobacteria.
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